Regenxbio

Chasing Pfizer and Roche, Regenxbio benefits from FDA boost for DMD gene therapy
Chasing Pfizer and Roche, Regenxbio benefits from FDA boost for DMD gene therapy
Fierce Biotech
Regenxbio
adeno-associated viruses
Duchenne Muscular Dystrophy
FDA
Flag link:
Duchenne muscular dystrophy’s progress so far in 2023
Duchenne muscular dystrophy’s progress so far in 2023
Clinical Trials Arena
Duchenne Muscular Dystrophy
DMD
Santhera Pharmaceuticals
ReveraGen
vamorolone
Regenxbio
RGX-202
Flag link:
RegenXBio gets FDA support for Hunter syndrome gene therapy's accelerated review filing—in 2024
RegenXBio gets FDA support for Hunter syndrome gene therapy's accelerated review filing—in 2024
Fierce Biotech
Regenxbio
Hunter Syndrome
RGX-121
accelerated approval
FDA
Flag link:
Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents
Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents
Endpoints
Amgen
GSK
Regenxbio
Supreme Court
innovation
patents
Flag link:
Regenxbio expands MPS I gene therapy trial after first look at data
Regenxbio expands MPS I gene therapy trial after first look at data
Pharmaforum
Regenxbio
gene therapy
Hurler Syndrome
RGX-111
Flag link:
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
Motley Fool
AbbVie
Regenxbio
gene therapy
wet age-related macular degeneration
Flag link:
Zolgensma patent spat brews between Novartis and Regenxbio as top Novartis gene therapy exec departs
Zolgensma patent spat brews between Novartis and Regenxbio as top Novartis gene therapy exec departs
Endpoints
Regenxbio
gene therapy
patents
Novartis
Zolgensma
SMA
Flag link:
AbbVie, Regenxbio enter deal to develop retinal disease therapy
AbbVie, Regenxbio enter deal to develop retinal disease therapy
Reuters
AbbVie
Regenxbio
RGX-314
gene therapy
retinal disease
Flag link:
Sarepta faces another gene therapy hiccup as Regenxbio sues over Jim Wilson's patent
Sarepta faces another gene therapy hiccup as Regenxbio sues over Jim Wilson's patent
Endpoints
Sarepta Therapeutics
gene therapy
Regenxbio
Duchenne Muscular Dystrophy
Flag link:
Regenxbio sues FDA over gene therapy clinical hold
Regenxbio sues FDA over gene therapy clinical hold
Fierce Biotech
Regenxbio
FDA
clinical hold
gene therapy
clinical trials
Flag link:
Big Pharma Has Mad Love For These 2 Biotechs
Big Pharma Has Mad Love For These 2 Biotechs
Motley Fool
Big Pharma
biotechs
Regenxbio
Denali Therapeutics
Flag link:
More M&A Activity Expected Around AAV-Based Gene Therapies, Analyst Says
More M&A Activity Expected Around AAV-Based Gene Therapies, Analyst Says
BioSpace
gene therapy
M&A
Audentes Therapeutics
Regenxbio
Passage Bio
Flag link:
RegenxBio and Pfizer Partner on Gene Therapy for Friedreich's Ataxia
RegenxBio and Pfizer Partner on Gene Therapy for Friedreich's Ataxia
BioSpace
Regenxbio
Pfizer
gene therapy
Friedreich's Ataxia
Flag link:
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Flag link:
RegenxBio rally fades fast after biotech reports setbacks, hospitalization in gene therapy study
RegenxBio rally fades fast after biotech reports setbacks, hospitalization in gene therapy study
Endpoints
Regenxbio
gene therapy
RGX-501
clinical trials
HoFH
Flag link:
Bidding war erupts over Dimension’s gene therapy pipeline as Ultragenyx counters Regenxbio deal
Bidding war erupts over Dimension’s gene therapy pipeline as Ultragenyx counters Regenxbio deal
Endpoints
Dimension Therapeutics
Ultragenyx
Regenxbio
gene therapy
R&D
Flag link:
Regenxbio to buy battered Dimension for gene therapies
Regenxbio to buy battered Dimension for gene therapies
Fierce Biotech
Regenxbio
Dimension Therapeutics
gene therapies
M&A
Flag link:
Amgen signs licensing deal for Regenxbio gene therapy technology
Amgen signs licensing deal for Regenxbio gene therapy technology
Bizjournals.com
Amgen
gene therapy
Regenxbio
NAV technology
Flag link: